FDA Approves Supplement for Deutetrabenazine by Aurobindo Pharma
The FDA has approved a supplemental application for deutetrabenazine submitted by Aurobindo Pharma.
Asset / Drug
Drug and asset intelligence for deutetrabenazine with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Topline Data
July 12, 2026 · N/A
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.